Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C1QTNF7 antisense RNA 1 (C1QTNF7-AS1)
- Target
- C1QTNF7-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Natural antisense transcript, Non-protein-coding RNA
01
Overview
C1QTNF7 antisense RNA 1 (C1QTNF7-AS1) is a long non-coding RNA gene located antisense to the C1QTNF7 (C1q and tumor necrosis factor related protein 7) gene. Like other long antisense RNAs, it is presumed to regulate expression of its sense gene or neighboring genes via transcriptional and post-transcriptional mechanisms typical for lncRNAs, including chromatin remodeling, RNA duplex formation, or microRNA sponging. There are currently no detailed experimental studies describing the specific molecular functions or disease associations of C1QTNF7-AS1. It is cataloged in reference genomic databases (HGNC:40683, Ensembl:ENSG00000249252, NCBI Gene:101929095). No clinical, diagnostic, or therapeutic relevance has been formally established yet.
- Other names
- C1QTNF7-AS1C1QTNF7 antisense RNA 1
02
Mechanism of action
There are no known drugs or small molecules with a defined mechanism of action targeting C1QTNF7-AS1.
03
Biological functions
Gene expression regulation: Antisense RNAs, including C1QTNF7-AS1, typically regulate the expression of their sense partner gene or neighboring genes by various mechanisms, including transcriptional interference, mRNA stabilization/destabilization, chromatin remodeling, or microRNA spongingPrecise biological functions for C1QTNF7-AS1 specifically are not defined in the current literature.
04
Disease associations
No direct evidence currently links C1QTNF7-AS1 to specific diseases in the provided literature.By analogy to other antisense RNAs, possible but unestablished roles in cancer, neurodegeneration, metabolic diseases, or immune regulation may exist; these remain to be experimentally demonstrated
05
Safety considerations
None reported; not relevant for this molecular class as no specific inhibitors, antagonists, or activating drugs exist targeting this antisense RNA
06
Biomarkers
No validated disease or therapeutic biomarkers associated with C1QTNF7-AS1 are reported.Long non-coding antisense RNAs in general can be explored as *putative biomarkers* in biomedical research, but no specific adoption for C1QTNF7-AS1 is established
Beyond the preview
Go deeper on C1QTNF7 antisense RNA 1 (C1QTNF7-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on C1QTNF7 antisense RNA 1 (C1QTNF7-AS1).